GlaxoSmithKline logo

GSK worldwide

GSK announces full-year results 2011

Sir Andrew Witty - Q4 results

GSK announces Q4 and full-year results for 2011.

Details plus CEO and CFO interviews available in the Investors section of this website.


Fighting lymphatic filariasis

In 1998 GSK formed a partnership with the world health organisation to eliminate LF through the donation of its antiparasitic medicine, albendazole

More about our commitment to eliminate lymphatic filariasis

Corporate press releases

These press releases are intended for business journalists
and analysts/investors.

07 February 2012
GSK results announcement for Q4 and full year 2011

30 January 2012
GSK joins new global partnership to help defeat ten neglected tropical diseases by 2020

27 January 2012
GSK announces changes to the Board

Press release archive

Investors

LSE
1,393p
-13.50

08 Feb 2012 04:35 pm BST
NYSE
44.35
-0.45

08 Feb 2012 04:01 pm EDT
London Stock Exchange price updated every 15 minutes. Provided by Investis Limited.

Products

Prescription medicines


Vaccines


Consumer brands